Relationships among KRAS mutation status, expression of RAS pathway signaling molecules, and clinicopathological features and prognosis of patients with colorectal cancer-Reference-Cited by-同舟云学术

Relationships among KRAS mutation status, expression of RAS pathway signaling molecules, and clinicopathological features and prognosis of patients with colorectal cancer

Published:2019-02-21 Issue:7 Volume:25 Page:808-823
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:WJG

Author:

Wan Xiang-Bin,Wang Ai-Qin,Cao Jian,Dong Zhi-Chuang,Li Ning,Yang Sen,Sun Miao-Miao,Li Zhi,Luo Su-Xia

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference40 articles.

1. Cancer statistics, 2018

2. Yang L, Zheng R, Wang N, Yuan Y, Liu S, Li H, Zhang S, Zeng H, Chen W. Incidence and mortality of stomach cancer in China, 2014. Zhongguo Aizheng Yanjiu 2018; 30: 291-298

3. Cancer incidence in Beijing, 2014

4. Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights

5. The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omics-based molecular classifications empowering in precision oncology;Cellular Oncology;2024-01-31

2. The relationship of KRAS expression with KRAS status, prognosis, and tumor-infiltrated T lymphocytes in colorectal cancer;Therapeutic Advances in Gastroenterology;2024-01

3. Different oncological features of colorectal cancer codon-specific KRAS mutations: Not codon 13 but codon 12 have prognostic value;World Journal of Gastroenterology;2023-08-28

4. Evaluating whether KRAS/BRAF mutation status, anaemia and obstruction are associated with recurrence and mortality in non‐metastatic colorectal cancer;ANZ Journal of Surgery;2023-04-23

5. Peptidomic changes in human serous colorectal cancer patients;Journal of Gastrointestinal Oncology;2023-04